2020 Global Infectious Disease Molecular Diagnostics Market: US, Europe, Japan-Suppliers Shares and Sales Segment Forecasts for 100 Tests, Emerging Technologies, Competitive Analysis
The report is available by country, section, market segment, individual test, and can be custom-tailored to your specific information needs and budget.
This new seven-country study from VPGMarketResearch contains 775 pages, 197 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years.
Report Highlights
The infectious disease molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.
In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.
Geographic Coverage
Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.
Comprehensive listings of companies developing and marketing infectious disease molecular diagnostic products, by test and application.
Opportunities and Strategic Recommendations
This new seven-country study from VPGMarketResearch contains 775 pages, 197 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years.
Report Highlights
- Business and technological trends in major markets
- Five-year test volume and sales forecasts
- Market shares of leading competitors
- Feature comparison of major analyzers
- Strategic profiles of leading market players and start-up firms developing innovative products
- Specific product and business opportunities for instrument and consumable suppliers.
The infectious disease molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.
In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.
Geographic Coverage
- France
- Germany
- Italy
- Japan
- Spain
- UK
- USA
- Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases by country and market segment.
- Five-year test volume and sales projections by country.
- Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components.
- Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays.
- A comprehensive analysis of the sequencing market by country and laboratory segment.
- Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers by country.
- Comparison of leading infectious disease molecular diagnostic analyzers.
- Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods.
- Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products.
Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.
Comprehensive listings of companies developing and marketing infectious disease molecular diagnostic products, by test and application.
Opportunities and Strategic Recommendations
- Specific new product development opportunities with potentially significant market appeal during the next five years.
- Design criteria for new products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
- Business planning issues and concerns.
I. INTRODUCTION
II. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Computers, Software and Automation
D. Auxiliary Products
III. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
IV. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies For Decentralized Testing Markets
V. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge And Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. WORLDWIDE MARKET AND TECHNOLOGY REVIEW
A. DNA Sequencing
1. Introduction
2. Sequencing Methods
3. Autoradiography
4. The Human Genome Project
5. Sequencing Automation
6. Image Scanners
7. Fluorescent Detection
8. Gene Profiling
9. Gene Expression
10. Polymorphism Screening
11. Protein Interaction Networks
B. DNA and RNA Probe Technologies
1. Basic Principles
2. Probe Preparation
3. The DNA Probe Test
4. Test Formats
5. Labeling Techniques
6. Amplification Methods
C. Detection Technologies
1. Radioactive Methods
a. Overview
b. Major Isotopes
P-32
S-35
H-3
I-125
2. Non-Isotopic Methods
a. Enzymatic Labels
b. Chemical Labeling
Indirect Chemical Labeling
Direct Chemical Labeling
c. Fluorescence
d. Chemiluminescence
e. Electrical Conductivity
D. Molecular Diagnostic Instrumentation Review
1. Abbott LCx
2. Beckman Coulter/Biomek FK
3. BD Viper System with XTR Technology
4. BD Innova
5. Becton Dickinson SDA
6. bioMerieux NucliSENS easyMAG
7. bioMerieux NucliSENS easyQ and MiniMAG
8. Bio-Rad GeneScope
9. Cepheid GeneXpert
10. Curetis Unyvero
11. GenMark Dx eSensor XT-8
12. Hologic/Gen-Probe Panther
13. Hologic/Gen-Probe Tigris/DTS
14. HTG Molecular Edge
15. Life Technologies QuantStudio Dx
16. Qiagen QIAsymphony RGQ
17. Roche Cobas Amplicor
18. Roche Cobas TaqMan
19. Roche Cobas TaqMan
20. Roche Cobas TaqMan AmpliPrep
21. Roche LighCycler
22. Roche Cobas 4800
23. Roche Cobas s
24. Siemens Versant
25. Tecan LS Series
E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
Liquid Transportation and Mixing
Separation
Reaction
Detection
F. Pharmacogenomics
G. Major Applications, Microbiology/Infectious Diseases
a. Overview
b. Major Infectious Diseases
AIDS: HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
Adenovirus
Aeromonas
Anthrax/Bacillus Anthracis
Arboviruses
Babesiosis
Bacillary Epithelioid Angiomatosis (BEA) and Other Bartonella (Rochalimaea)
Blastocystis Hominis
Brucella
Campylobacter
Candida
Chagas Disease
Chancroid
Chlamydia
Clostridium Difficile
Coronaviruses
Coxsackieviruses
Creutzfeldt-Jakob’s Disease
Cryptosporidium Parvum
Cyclospora Cayetanensis
Cytomegalovirus
Ebola Virus
E. Coli
EchoVirus
Encephalitis
Enteroviruses
Epstein-Barr Virus
Giardia Lamblia
Gonorrhea
Granuloma Inguinale
Hantavirus
Helicobacter Pylori
Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, ALT/SGPT
Herpes Simplex Virus
Human Herpes Virus-6 (HHV-6)
Influenza Viruses
Legionella
Lyme Disease
Lymphogranuloma Venereum (LGV)
Malaria
Measles (Rubeola)
Meningitis
Microsporidium
Mononucleosis
Mumps
Mycoplasma
Papillomaviruses
Parvovirus B19
Pneumonia
Polyomaviruses
Pseudomonas Aeruginosa
Rabies
Respiratory Syncytial Virus (RSV)
Rhinoviruses
Rotavirus
Rubella
Salmonellosis
Septicemia
Shigellosis
Staphylococcus Aureus
Streptococci
Syphilis
Toxoplasmosis
Trichomonas Vaginalis
Tuberculosis
Vibrio
West Nile Virus
Yersina
H. Competing/complementing
1. Monoclonal Antibodies/Immunoassays
2. RNA Probes
3. Two-Dimensional Electrophoresis
4. Flow Cytometry
VII. WORLDWIDE MARKET OVERVIEW
1. Business Environment
2. Market Structure
3. Market Size and Growth
VIII. FRANCE MOLECULAR DIAGNOSTICS MARKET
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares
IX. GERMANY MOLECULAR DIAGNOSTICS MARKET
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares
X. ITALY MOLECULAR DIAGNOSTICS MARKET
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares
XI. JAPAN MOLECULAR DIAGNOSTICS MARKET
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares
XII. SPAIN MOLECULAR DIAGNOSTICS MARKET
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares
XIII. U.K. MOLECULAR DIAGNOSTICS MARKET
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares
XIV. U.S.A. MOLECULAR DIAGNOSTICS MARKET
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares
XV. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Biotest
Cepheid
Decode Genetics
Diadexus
Eiken Chemical
Elitech Group
Enzo Biochem
Exact Sciences
Fujirebio
Grifols
Hologic
Illumina
LabCorp
Leica Biosystems
Li-Cor Biosciences
Myriad Genetics
Ortho-Clinical Diagnostics
PerkinElmer
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
Shimadzu
Siemens Healthineers
Sierra Molecular
Takara Bio
Tecan Group
Thermo Fisher
XVI. APPENDIX: MAJOR UNIVERSITIES AND RESEARCH CENTERS DEVELOPING MOLECULAR DIAGNOSTIC TECHNOLOGIES
II. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Computers, Software and Automation
D. Auxiliary Products
III. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
IV. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies For Decentralized Testing Markets
V. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge And Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. WORLDWIDE MARKET AND TECHNOLOGY REVIEW
A. DNA Sequencing
1. Introduction
2. Sequencing Methods
3. Autoradiography
4. The Human Genome Project
5. Sequencing Automation
6. Image Scanners
7. Fluorescent Detection
8. Gene Profiling
9. Gene Expression
10. Polymorphism Screening
11. Protein Interaction Networks
B. DNA and RNA Probe Technologies
1. Basic Principles
2. Probe Preparation
3. The DNA Probe Test
4. Test Formats
5. Labeling Techniques
6. Amplification Methods
C. Detection Technologies
1. Radioactive Methods
a. Overview
b. Major Isotopes
P-32
S-35
H-3
I-125
2. Non-Isotopic Methods
a. Enzymatic Labels
b. Chemical Labeling
Indirect Chemical Labeling
Direct Chemical Labeling
c. Fluorescence
d. Chemiluminescence
e. Electrical Conductivity
D. Molecular Diagnostic Instrumentation Review
1. Abbott LCx
2. Beckman Coulter/Biomek FK
3. BD Viper System with XTR Technology
4. BD Innova
5. Becton Dickinson SDA
6. bioMerieux NucliSENS easyMAG
7. bioMerieux NucliSENS easyQ and MiniMAG
8. Bio-Rad GeneScope
9. Cepheid GeneXpert
10. Curetis Unyvero
11. GenMark Dx eSensor XT-8
12. Hologic/Gen-Probe Panther
13. Hologic/Gen-Probe Tigris/DTS
14. HTG Molecular Edge
15. Life Technologies QuantStudio Dx
16. Qiagen QIAsymphony RGQ
17. Roche Cobas Amplicor
18. Roche Cobas TaqMan
19. Roche Cobas TaqMan
20. Roche Cobas TaqMan AmpliPrep
21. Roche LighCycler
22. Roche Cobas 4800
23. Roche Cobas s
24. Siemens Versant
25. Tecan LS Series
E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
Liquid Transportation and Mixing
Separation
Reaction
Detection
F. Pharmacogenomics
G. Major Applications, Microbiology/Infectious Diseases
a. Overview
b. Major Infectious Diseases
AIDS: HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
Adenovirus
Aeromonas
Anthrax/Bacillus Anthracis
Arboviruses
Babesiosis
Bacillary Epithelioid Angiomatosis (BEA) and Other Bartonella (Rochalimaea)
Blastocystis Hominis
Brucella
Campylobacter
Candida
Chagas Disease
Chancroid
Chlamydia
Clostridium Difficile
Coronaviruses
Coxsackieviruses
Creutzfeldt-Jakob’s Disease
Cryptosporidium Parvum
Cyclospora Cayetanensis
Cytomegalovirus
Ebola Virus
E. Coli
EchoVirus
Encephalitis
Enteroviruses
Epstein-Barr Virus
Giardia Lamblia
Gonorrhea
Granuloma Inguinale
Hantavirus
Helicobacter Pylori
Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, ALT/SGPT
Herpes Simplex Virus
Human Herpes Virus-6 (HHV-6)
Influenza Viruses
Legionella
Lyme Disease
Lymphogranuloma Venereum (LGV)
Malaria
Measles (Rubeola)
Meningitis
Microsporidium
Mononucleosis
Mumps
Mycoplasma
Papillomaviruses
Parvovirus B19
Pneumonia
Polyomaviruses
Pseudomonas Aeruginosa
Rabies
Respiratory Syncytial Virus (RSV)
Rhinoviruses
Rotavirus
Rubella
Salmonellosis
Septicemia
Shigellosis
Staphylococcus Aureus
Streptococci
Syphilis
Toxoplasmosis
Trichomonas Vaginalis
Tuberculosis
Vibrio
West Nile Virus
Yersina
H. Competing/complementing
1. Monoclonal Antibodies/Immunoassays
2. RNA Probes
3. Two-Dimensional Electrophoresis
4. Flow Cytometry
VII. WORLDWIDE MARKET OVERVIEW
1. Business Environment
2. Market Structure
3. Market Size and Growth
VIII. FRANCE MOLECULAR DIAGNOSTICS MARKET
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares
IX. GERMANY MOLECULAR DIAGNOSTICS MARKET
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares
X. ITALY MOLECULAR DIAGNOSTICS MARKET
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares
XI. JAPAN MOLECULAR DIAGNOSTICS MARKET
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares
XII. SPAIN MOLECULAR DIAGNOSTICS MARKET
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares
XIII. U.K. MOLECULAR DIAGNOSTICS MARKET
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares
XIV. U.S.A. MOLECULAR DIAGNOSTICS MARKET
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares
XV. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Biotest
Cepheid
Decode Genetics
Diadexus
Eiken Chemical
Elitech Group
Enzo Biochem
Exact Sciences
Fujirebio
Grifols
Hologic
Illumina
LabCorp
Leica Biosystems
Li-Cor Biosciences
Myriad Genetics
Ortho-Clinical Diagnostics
PerkinElmer
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
Shimadzu
Siemens Healthineers
Sierra Molecular
Takara Bio
Tecan Group
Thermo Fisher
XVI. APPENDIX: MAJOR UNIVERSITIES AND RESEARCH CENTERS DEVELOPING MOLECULAR DIAGNOSTIC TECHNOLOGIES
LIST OF TABLES
Major Companies Developing or Marketing AIDS Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Bartonella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Campylobacter Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Candida Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Chlamydia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Clostridium Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Coronavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Cryptosporidium Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing CMV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Echovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Enterovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Giardia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hantavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Helicobacter Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hepatitis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Herpes Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Influenza Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Legionella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Measles Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Meningitis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mononucleosis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mumps Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Pneumonia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing RSV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rotavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rubella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Salmonella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Septicemia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Shigella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Streptococci Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Syphilis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Trichomonas Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic and Other Direct Identification Tests
Worldwide, Laboratories Performing DNA Sequencing by Country
Worldwide, Molecular Diagnostics Market Potential Laboratory Universe by Country
Worldwide, Molecular Diagnostic Test Volume Forecast by Country
Worldwide, Molecular Diagnostics Market Forecast by Country
France
Molecular Diagnostics Test Volume And Sales By Major Application
France
Laboratories Performing DNA Sequencing By Market Segment
France
Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
France
Molecular Diagnostics Test Volume By Major Application
France
Major Infectious Disease Test Volume by Assay
France
Major Infectious Disease Test Volume by Method
France
Molecular Diagnostics Market By Major Application
France
Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
France
Major Infectious Disease Diagnostics Market by Assay
France
AIDS Testing Market Estimated Sales by Major Supplier
France
Adenovirus Testing Market Estimated Sales by Major Supplier
France
Chlamydia Testing Market Estimated Sales by Major Supplier
France
CMV Testing Market Estimated Sales by Major Supplier
France
Gonorrhea Testing Market Estimated Sales by Major Supplier
France
Hepatitis Testing Market Estimated Sales by Major Supplier
France
Hepatitis C Testing Market Estimated Sales by Major Supplier
France
HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
France
Herpes Testing Market Estimated Sales by Major Supplier
France
Influenza Testing Market Estimated Sales by Major Supplier
France
Meningitis Testing Market Estimated Sales by Major Supplier
France
Mycoplasma Testing Market Estimated Sales by Major Supplier
France
RSV Testing Market Estimated Sales by Major Supplier
France
Shigella Testing Market Estimated Sales by Major Supplier
Germany
Molecular Diagnostics Test Volume And Sales By Major Application
Germany
Laboratories Performing DNA Sequencing By Market Segment
Germany
Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Germany
Molecular Diagnostics Test Volume By Major Application
Germany
Major Infectious Disease Test Volume by Assay
Germany
Major Infectious Disease Test Volume by Method
Germany
Molecular Diagnostics Market By Major Application
Germany
Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
Germany
Major Infectious Disease Diagnostics Market by Assay
Germany
AIDS Testing Market Estimated Sales by Major Supplier
Germany
CMV Testing Market Estimated Sales by Major Supplier
Germany
EBV Testing Market Estimated Sales by Major Supplier
Germany
Gonorrhea Testing Market Estimated Sales by Major Supplier
Germany
Hepatitis Testing Market Estimated Sales by Major Supplier
Germany
Hepatitis C Testing Market Estimated Sales by Major Supplier
Germany
HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
Germany
Herpes Testing Market Estimated Sales by Major Supplier
Germany
Influenza Testing Market Estimated Sales by Major Supplier
Germany
Meningitis Testing Market Estimated Sales by Major Supplier
Germany
Mycoplasma Testing Market Estimated Sales by Major Supplier
Germany
Pneumonia Testing Market Estimated Sales by Major Supplier
Germany
RSV Testing Market Estimated Sales by Major Supplier
Germany
Rotavirus Testing Market Estimated Sales by Major Supplier
Italy
Molecular Diagnostics Test Volume And Sales By Major Application
Italy
Laboratories Performing DNA Sequencing By Market Segment
Italy
Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Italy
Molecular Diagnostics Test Volume By Major Application
Italy
Major Infectious Disease Test Volume by Assay
Italy
Major Infectious Disease Test Volume by Method
Italy
Molecular Diagnostics Market By Major Application
Italy
Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
Italy
Major Infectious Disease Diagnostics Market by Assay
Italy
AIDS Testing Market Estimated Sales by Major Supplier
Italy
CMV Testing Market Estimated Sales by Major Supplier
Italy
Gonorrhea Testing Market Estimated Sales by Major Supplier
Italy
Hepatitis Testing Market Estimated Sales by Major Supplier
Italy
Hepatitis C Testing Market Estimated Sales by Major Supplier
Italy
HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
Italy
Herpes Testing Market Estimated Sales by Major Supplier
Italy
Influenza Testing Market Estimated Sales by Major Supplier
Italy
Meningitis Testing Market Estimated Sales by Major Supplier
Italy
Mycoplasma Testing Market Estimated Sales by Major Supplier
Italy
RSV Testing Market Estimated Sales by Major Supplier
Japan
Molecular Diagnostics Test Volume And Sales By Major Application
Japan
Laboratories Performing DNA Sequencing By Market Segment
Japan
Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Japan
Molecular Diagnostics Test Volume By Major Application
Japan
Major Infectious Disease Test Volume by Assay
Japan
Major Infectious Disease Test Volume by Method
Japan
Molecular Diagnostics Market By Major Application
Japan
Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
Japan
Major Infectious Disease Diagnostics Market by Assay
Japan
AIDS Testing Market Estimated Sales by Major Supplier
Japan
Chlamydia Testing Market Estimated Sales by Major Supplier
Japan
CMV Testing Market Estimated Sales by Major Supplier
Japan
Gonorrhea Testing Market Estimated Sales by Major Supplier
Japan
Hepatitis Testing Market Estimated Sales by Major Supplier
Japan
Hepatitis C Testing Market Estimated Sales by Major Supplier
Japan
Herpes Testing Market Estimated Sales by Major Supplier
Japan
Meningitis Testing Market Estimated Sales by Major Supplier
Japan
Mycoplasma Testing Market Estimated Sales by Major Supplier
Japan
Pneumonia Testing Market Estimated Sales by Major Supplier
Japan
Shigella Testing Market Estimated Sales by Major Supplier
Spain
Molecular Diagnostics Test Volume And Sales By Major Application
Spain
Laboratories Performing DNA Sequencing By Market Segment
Spain
Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Spain
Molecular Diagnostics Test Volume By Major Application
Spain
Major Infectious Disease Test Volume by Assay
Spain
Major Infectious Disease Test Volume by Method
Spain
Molecular Diagnostics Market By Major Application
Spain
Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
Spain
Major Infectious Disease Diagnostics Market by Assay
Spain
AIDS Testing Market Estimated Sales by Major Supplier
Spain
Chlamydia Testing Market Estimated Sales by Major Supplier
Spain
CMV Testing Market Estimated Sales by Major Supplier
Spain
Gonorrhea Testing Market Estimated Sales by Major Supplier
Spain
Hepatitis Testing Market Estimated Sales by Major Supplier
Spain
Hepatitis C Testing Market Estimated Sales by Major Supplier
Spain
HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
Spain
Herpes Testing Market Estimated Sales by Major Supplier
Spain
Influenza Testing Market Estimated Sales by Major Supplier
Spain
Meningitis Testing Market Estimated Sales by Major Supplier
Spain
Mycoplasma Testing Market Estimated Sales by Major Supplier
U.K.
Molecular Diagnostics Test Volume And Sales By Major Application
U.K.
Laboratories Performing DNA Sequencing By Market Segment
U.K.
Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
U.K.
Molecular Diagnostics Test Volume By Major Application
U.K.
Major Infectious Disease Test Volume by Assay
U.K.
Major Infectious Disease Test Volume by Method
U.K.
Molecular Diagnostics Market By Major Application
U.K.
Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
U.K.
Major Infectious Disease Diagnostics Market by Assay
U.K.
AIDS Testing Market Estimated Sales by Major Supplier
U.K.
Gonorrhea Testing Market Estimated Sales by Major Supplier
U.K.
Hepatitis Testing Market Estimated Sales by Major Supplier
U.K.
Hepatitis C Testing Market Estimated Sales by Major Supplier
U.K.
HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
U.K.
Influenza Testing Market Estimated Sales by Major Supplier
U.K.
Mycoplasma Testing Market Estimated Sales by Major Supplier
U.K.
Pneumonia Testing Market Estimated Sales by Major Supplier
U.K.
Shigella Testing Market Estimated Sales by Major Supplier
U.S.A.
Molecular Diagnostics Test Volume And Sales By Major Application
U.S.A.
Laboratories Performing DNA Sequencing By Market Segment
U.S.A.
Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
U.S.A.
Molecular Diagnostics Test Volume by Major Application
U.S.A.
Major Infectious Disease Test Volume by Assay
U.S.A.
Major Infectious Disease Test Volume by Method
U.S.A.
Molecular Diagnostics Market By Major Application
U.S.A.
Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
U.S.A.
Major Infectious Disease Diagnostics Market by Assay
U.S.A.
AIDS Testing Market Estimated Sales by Major Supplier
U.S.A.
Adenovirus Testing Market Estimated Sales by Major Supplier
U.S.A.
Chlamydia Testing Market Estimated Sales by Major Supplier
U.S.A.
CMV Testing Market Estimated Sales by Major Supplier
U.S.A.
Echovirus Testing Market Estimated Sales by Major Supplier
U.S.A.
Enterovirus Testing Market Estimated Sales by Major Supplier
U.S.A.
EBV Testing Market Estimated Sales by Major Supplier
U.S.A.
Gonorrhea Testing Market Estimated Sales by Major Supplier
U.S.A.
Hepatitis Testing Market Estimated Sales by Major Supplier
U.S.A.
Hepatitis C Testing Market Estimated Sales by Major Supplier
U.S.A.
HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
U.S.A.
Herpes Testing Market Estimated Sales by Major Supplier
U.S.A.
Influenza Testing Market Estimated Sales by Major Supplier
U.S.A.
Meningitis Testing Market Estimated Sales by Major Supplier
U.S.A.
Mycoplasma Testing Market Estimated Sales by Major Supplier
U.S.A.
Pneumonia Testing Market Estimated Sales by Major Supplier
U.S.A.
Rabies Testing Market Estimated Sales by Major Supplier
U.S.A.
RSV Testing Market Estimated Sales by Major Supplier
U.S.A.
Salmonella Testing Market Estimated Sales by Major Supplier
U.S.A.
Shigella Testing Market Estimated Sales by Major Supplier
U.S.A.
West Nile Virus Nat Market Reagent Sales by Major Supplier
Major Companies Developing or Marketing AIDS Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Bartonella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Campylobacter Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Candida Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Chlamydia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Clostridium Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Coronavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Cryptosporidium Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing CMV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Echovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Enterovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Giardia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hantavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Helicobacter Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hepatitis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Herpes Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Influenza Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Legionella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Measles Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Meningitis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mononucleosis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mumps Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Pneumonia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing RSV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rotavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rubella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Salmonella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Septicemia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Shigella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Streptococci Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Syphilis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Trichomonas Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic and Other Direct Identification Tests
Worldwide, Laboratories Performing DNA Sequencing by Country
Worldwide, Molecular Diagnostics Market Potential Laboratory Universe by Country
Worldwide, Molecular Diagnostic Test Volume Forecast by Country
Worldwide, Molecular Diagnostics Market Forecast by Country
France
Molecular Diagnostics Test Volume And Sales By Major Application
France
Laboratories Performing DNA Sequencing By Market Segment
France
Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
France
Molecular Diagnostics Test Volume By Major Application
France
Major Infectious Disease Test Volume by Assay
France
Major Infectious Disease Test Volume by Method
France
Molecular Diagnostics Market By Major Application
France
Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
France
Major Infectious Disease Diagnostics Market by Assay
France
AIDS Testing Market Estimated Sales by Major Supplier
France
Adenovirus Testing Market Estimated Sales by Major Supplier
France
Chlamydia Testing Market Estimated Sales by Major Supplier
France
CMV Testing Market Estimated Sales by Major Supplier
France
Gonorrhea Testing Market Estimated Sales by Major Supplier
France
Hepatitis Testing Market Estimated Sales by Major Supplier
France
Hepatitis C Testing Market Estimated Sales by Major Supplier
France
HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
France
Herpes Testing Market Estimated Sales by Major Supplier
France
Influenza Testing Market Estimated Sales by Major Supplier
France
Meningitis Testing Market Estimated Sales by Major Supplier
France
Mycoplasma Testing Market Estimated Sales by Major Supplier
France
RSV Testing Market Estimated Sales by Major Supplier
France
Shigella Testing Market Estimated Sales by Major Supplier
Germany
Molecular Diagnostics Test Volume And Sales By Major Application
Germany
Laboratories Performing DNA Sequencing By Market Segment
Germany
Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Germany
Molecular Diagnostics Test Volume By Major Application
Germany
Major Infectious Disease Test Volume by Assay
Germany
Major Infectious Disease Test Volume by Method
Germany
Molecular Diagnostics Market By Major Application
Germany
Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
Germany
Major Infectious Disease Diagnostics Market by Assay
Germany
AIDS Testing Market Estimated Sales by Major Supplier
Germany
CMV Testing Market Estimated Sales by Major Supplier
Germany
EBV Testing Market Estimated Sales by Major Supplier
Germany
Gonorrhea Testing Market Estimated Sales by Major Supplier
Germany
Hepatitis Testing Market Estimated Sales by Major Supplier
Germany
Hepatitis C Testing Market Estimated Sales by Major Supplier
Germany
HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
Germany
Herpes Testing Market Estimated Sales by Major Supplier
Germany
Influenza Testing Market Estimated Sales by Major Supplier
Germany
Meningitis Testing Market Estimated Sales by Major Supplier
Germany
Mycoplasma Testing Market Estimated Sales by Major Supplier
Germany
Pneumonia Testing Market Estimated Sales by Major Supplier
Germany
RSV Testing Market Estimated Sales by Major Supplier
Germany
Rotavirus Testing Market Estimated Sales by Major Supplier
Italy
Molecular Diagnostics Test Volume And Sales By Major Application
Italy
Laboratories Performing DNA Sequencing By Market Segment
Italy
Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Italy
Molecular Diagnostics Test Volume By Major Application
Italy
Major Infectious Disease Test Volume by Assay
Italy
Major Infectious Disease Test Volume by Method
Italy
Molecular Diagnostics Market By Major Application
Italy
Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
Italy
Major Infectious Disease Diagnostics Market by Assay
Italy
AIDS Testing Market Estimated Sales by Major Supplier
Italy
CMV Testing Market Estimated Sales by Major Supplier
Italy
Gonorrhea Testing Market Estimated Sales by Major Supplier
Italy
Hepatitis Testing Market Estimated Sales by Major Supplier
Italy
Hepatitis C Testing Market Estimated Sales by Major Supplier
Italy
HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
Italy
Herpes Testing Market Estimated Sales by Major Supplier
Italy
Influenza Testing Market Estimated Sales by Major Supplier
Italy
Meningitis Testing Market Estimated Sales by Major Supplier
Italy
Mycoplasma Testing Market Estimated Sales by Major Supplier
Italy
RSV Testing Market Estimated Sales by Major Supplier
Japan
Molecular Diagnostics Test Volume And Sales By Major Application
Japan
Laboratories Performing DNA Sequencing By Market Segment
Japan
Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Japan
Molecular Diagnostics Test Volume By Major Application
Japan
Major Infectious Disease Test Volume by Assay
Japan
Major Infectious Disease Test Volume by Method
Japan
Molecular Diagnostics Market By Major Application
Japan
Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
Japan
Major Infectious Disease Diagnostics Market by Assay
Japan
AIDS Testing Market Estimated Sales by Major Supplier
Japan
Chlamydia Testing Market Estimated Sales by Major Supplier
Japan
CMV Testing Market Estimated Sales by Major Supplier
Japan
Gonorrhea Testing Market Estimated Sales by Major Supplier
Japan
Hepatitis Testing Market Estimated Sales by Major Supplier
Japan
Hepatitis C Testing Market Estimated Sales by Major Supplier
Japan
Herpes Testing Market Estimated Sales by Major Supplier
Japan
Meningitis Testing Market Estimated Sales by Major Supplier
Japan
Mycoplasma Testing Market Estimated Sales by Major Supplier
Japan
Pneumonia Testing Market Estimated Sales by Major Supplier
Japan
Shigella Testing Market Estimated Sales by Major Supplier
Spain
Molecular Diagnostics Test Volume And Sales By Major Application
Spain
Laboratories Performing DNA Sequencing By Market Segment
Spain
Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Spain
Molecular Diagnostics Test Volume By Major Application
Spain
Major Infectious Disease Test Volume by Assay
Spain
Major Infectious Disease Test Volume by Method
Spain
Molecular Diagnostics Market By Major Application
Spain
Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
Spain
Major Infectious Disease Diagnostics Market by Assay
Spain
AIDS Testing Market Estimated Sales by Major Supplier
Spain
Chlamydia Testing Market Estimated Sales by Major Supplier
Spain
CMV Testing Market Estimated Sales by Major Supplier
Spain
Gonorrhea Testing Market Estimated Sales by Major Supplier
Spain
Hepatitis Testing Market Estimated Sales by Major Supplier
Spain
Hepatitis C Testing Market Estimated Sales by Major Supplier
Spain
HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
Spain
Herpes Testing Market Estimated Sales by Major Supplier
Spain
Influenza Testing Market Estimated Sales by Major Supplier
Spain
Meningitis Testing Market Estimated Sales by Major Supplier
Spain
Mycoplasma Testing Market Estimated Sales by Major Supplier
U.K.
Molecular Diagnostics Test Volume And Sales By Major Application
U.K.
Laboratories Performing DNA Sequencing By Market Segment
U.K.
Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
U.K.
Molecular Diagnostics Test Volume By Major Application
U.K.
Major Infectious Disease Test Volume by Assay
U.K.
Major Infectious Disease Test Volume by Method
U.K.
Molecular Diagnostics Market By Major Application
U.K.
Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
U.K.
Major Infectious Disease Diagnostics Market by Assay
U.K.
AIDS Testing Market Estimated Sales by Major Supplier
U.K.
Gonorrhea Testing Market Estimated Sales by Major Supplier
U.K.
Hepatitis Testing Market Estimated Sales by Major Supplier
U.K.
Hepatitis C Testing Market Estimated Sales by Major Supplier
U.K.
HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
U.K.
Influenza Testing Market Estimated Sales by Major Supplier
U.K.
Mycoplasma Testing Market Estimated Sales by Major Supplier
U.K.
Pneumonia Testing Market Estimated Sales by Major Supplier
U.K.
Shigella Testing Market Estimated Sales by Major Supplier
U.S.A.
Molecular Diagnostics Test Volume And Sales By Major Application
U.S.A.
Laboratories Performing DNA Sequencing By Market Segment
U.S.A.
Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
U.S.A.
Molecular Diagnostics Test Volume by Major Application
U.S.A.
Major Infectious Disease Test Volume by Assay
U.S.A.
Major Infectious Disease Test Volume by Method
U.S.A.
Molecular Diagnostics Market By Major Application
U.S.A.
Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
U.S.A.
Major Infectious Disease Diagnostics Market by Assay
U.S.A.
AIDS Testing Market Estimated Sales by Major Supplier
U.S.A.
Adenovirus Testing Market Estimated Sales by Major Supplier
U.S.A.
Chlamydia Testing Market Estimated Sales by Major Supplier
U.S.A.
CMV Testing Market Estimated Sales by Major Supplier
U.S.A.
Echovirus Testing Market Estimated Sales by Major Supplier
U.S.A.
Enterovirus Testing Market Estimated Sales by Major Supplier
U.S.A.
EBV Testing Market Estimated Sales by Major Supplier
U.S.A.
Gonorrhea Testing Market Estimated Sales by Major Supplier
U.S.A.
Hepatitis Testing Market Estimated Sales by Major Supplier
U.S.A.
Hepatitis C Testing Market Estimated Sales by Major Supplier
U.S.A.
HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
U.S.A.
Herpes Testing Market Estimated Sales by Major Supplier
U.S.A.
Influenza Testing Market Estimated Sales by Major Supplier
U.S.A.
Meningitis Testing Market Estimated Sales by Major Supplier
U.S.A.
Mycoplasma Testing Market Estimated Sales by Major Supplier
U.S.A.
Pneumonia Testing Market Estimated Sales by Major Supplier
U.S.A.
Rabies Testing Market Estimated Sales by Major Supplier
U.S.A.
RSV Testing Market Estimated Sales by Major Supplier
U.S.A.
Salmonella Testing Market Estimated Sales by Major Supplier
U.S.A.
Shigella Testing Market Estimated Sales by Major Supplier
U.S.A.
West Nile Virus Nat Market Reagent Sales by Major Supplier